Ozempic alternatives for weight loss

Ozempic is FDA-approved for blood sugar control in adults with type 2 diabetes, and to lower heart and kidney risks in that group. It has no weight-management indication, so prescribing it for weight loss is off-label. If weight loss is your goal, five medicines are FDA-approved for it, including two daily pills, and most cost less self-pay than Ozempic’s list price.

Here is how they compare on what the trials showed, how you take them and what they cost without insurance, as of October 2026.

The alternatives at a glance

Scroll sideways to see the full table

Self-pay prices are from NovoCare Pharmacy and LillyDirect as of October 2026. Zepbound’s $449 applies at 7.5 mg and above if you refill within 45 days; late refills cost $499 to $699.

Wegovy: the same drug, approved for weight loss

Wegovy is semaglutide, the active ingredient in Ozempic, at higher doses and approved for long-term weight reduction in adults and children 12 and older. It is also approved to lower the risk of heart attack, stroke and cardiovascular death in adults with heart disease and obesity or overweight. In the STEP 1 trial, people on 2.4 mg lost 14.9% of their body weight on average over 68 weeks, against 2.4% on placebo; the higher 7.2 mg dose produced 18.8% over 72 weeks in STEP UP.

Self-pay at NovoCare Pharmacy, the injection costs $199 a month for the first two fills (0.25 mg and 0.5 mg, for new patients through December 31, 2026), then $349 at every dose up to 2.4 mg, and $399 for 7.2 mg. If your commercial plan covers it, Novo’s savings offer can bring it to as little as $25 a month.

Pills instead of injections

Two daily pills are now approved for weight loss. The Wegovy pill is oral semaglutide, taken each morning on an empty stomach with up to 4 ounces of water, 30 minutes before food or other medicines. In OASIS 4, the 25 mg dose produced 13.6% average weight loss over 64 weeks. It costs $149 at 1.5 mg, $199 at 4 mg and $299 at 9 mg and 25 mg at NovoCare Pharmacy, labeled a limited-time offer.

Foundayo (orforglipron) is a different molecule, a non-peptide pill you can take at any time of day, with or without food. In ATTAIN-1, the 17.2 mg dose produced 11.1% average weight loss over 72 weeks, against 2.1% on placebo. LillyDirect charges $149 at 0.8 mg and 2.5 mg, $199 at 5.5 mg and $299 at 9 mg and up. See Foundayo vs the Wegovy pill for a closer comparison.

Zepbound: more weight loss on average

Zepbound is tirzepatide, which acts on two gut-hormone receptors rather than one. In SURMOUNT-1, people lost 15.0% (5 mg), 19.5% (10 mg) and 20.9% (15 mg) of their body weight on average over 72 weeks, against 3.1% on placebo. In the head-to-head SURMOUNT-5 trial of 751 adults, people on tirzepatide lost 20.2% over 72 weeks, against 13.7% on semaglutide.

Self-pay from LillyDirect, Zepbound costs $299 at 2.5 mg, $399 at 5 mg and $449 at 7.5 mg to 15 mg if you refill within 45 days. Vials and KwikPens cost the same. It is also approved for moderate to severe obstructive sleep apnea in adults with obesity. Our Wegovy vs Zepbound guide goes deeper.

Older and lower-cost options

Liraglutide, the drug in Saxenda, is a once-a-day injection approved for weight loss in adults and children 12 and older. In its main trial, people lost 7.4% of body weight on average over 56 weeks, against 3.0% on placebo, and the label says adults should stop if they haven’t lost at least 4% after 16 weeks. Teva launched the first generic in August 2025, and pharmacy prices vary.

Mounjaro is the same drug as Zepbound, approved for type 2 diabetes. Like Ozempic, it is off-label for weight loss alone, and for weight loss without diabetes, Zepbound is the version with self-pay pricing.

Compounded semaglutide

Many online programs sell compounded semaglutide at one monthly price. As of October 2026, it costs $89 to $299 a month at the 39 programs we rank, taking each program’s lowest ongoing monthly price with medication and any required membership included. That is lower than Wegovy’s self-pay price at most programs, but compounded semaglutide is not Ozempic or Wegovy, and not a generic of either. A compounding pharmacy prepares it, it isn’t FDA-approved, and the FDA doesn’t review compounded drugs for safety, effectiveness or quality. Since the semaglutide shortage ended in February 2025, pharmacies may compound it only for an individual patient’s needs. Read is compounded semaglutide still legal and safe before you choose it, and compare programs on our compounded semaglutide list.

Paying with insurance or Medicare

Coverage changes the math. If your commercial plan covers Wegovy or Zepbound, the manufacturers’ savings offers can bring your copay to as little as $25 a month; those offers exclude people with government insurance. Since July 1, 2026, eligible Medicare Part D enrollees can get Wegovy, the Zepbound KwikPen or Foundayo for $50 a month through the Medicare GLP-1 Bridge, after prior authorization, until December 31, 2027. See does insurance cover GLP-1s and does Medicare cover Wegovy or Zepbound.

Safety is similar across the class

Every GLP-1 medicine above carries a boxed warning for thyroid C-cell tumors, and none is for people with a personal or family history of medullary thyroid carcinoma or MEN 2. Nausea, diarrhea, vomiting and constipation are the most common side effects, usually while the dose is rising. Our GLP-1 side effects guide covers them in detail.

How to choose

• You want the same drug as Ozempic, approved for weight loss: Wegovy injection or pill.
• You want the most weight loss on average: Zepbound, based on SURMOUNT-1 and SURMOUNT-5.
• You’d rather not inject: the Wegovy pill or Foundayo, both from $149 a month self-pay.
• Price matters most and you accept a non-FDA-approved product: compounded semaglutide, from $89 a month.

Online programs can prescribe any of these after a review. Compare them on our best GLP-1 programs, brand-name GLP-1 programs and GLP-1 pill programs lists, or start at the weight loss hub.

The bottom line

Ozempic is a diabetes drug; for weight loss, Wegovy is the same medicine with the approval and a self-pay price of $349 to $399 a month after two $199 starter fills for new patients. Zepbound produced the most weight loss on average in trials, and costs $299 to $449 with on-time refills, while the Wegovy pill and Foundayo start at $149 if you’d rather take a pill. Generic liraglutide and compounded semaglutide cost less, with smaller trial results or no FDA approval. Ask a licensed clinician which fits your health and budget.